Serum soluble CD23 levels in giant cell arteritis' - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Immunology Letters Year : 1996

Serum soluble CD23 levels in giant cell arteritis'


Lymphocytes and monocytes express various levels of membrane-bound CD23, the low affinity receptor for IgE (FceRII), and in some cases release it as a soluble form. Soluble CD23 (sCD23) has been implicated in the regulation of many immunological functions of T and B lymphocytes, macrophages and myeloid cells in humans. To study serum sCD23 levels in inflammatory conditions, we selected a systemic disease sensitive to corticotherapy, the giant cell arteritis, which is characterized by an inflammation of the temporal artery. Serum sCD23 levels, as measured by a radioimmunoassay, were increased in these patients, and returned to normal values within the 24 h following initiation of corticotherapy. The data suggest that the increase in sCD23 levels in giant cell arteritis results from an overproduction.


Fichier principal
Vignette du fichier
serum CD23.pdf (350.18 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

inserm-03549093 , version 1 (31-01-2022)



Pascal Roblot, Franck Morel, Eric Lelièvre, Marie-Hélène Biais-Sauvètre, Donat de Groote, et al.. Serum soluble CD23 levels in giant cell arteritis'. Immunology Letters, 1996, 53 (1), pp.41. ⟨10.1016/0165-2478(96)02612-0⟩. ⟨inserm-03549093⟩


9 View
42 Download



Gmail Facebook X LinkedIn More